© 2026 Institute for Biotechnology and Medicine Industry & Research Center for Biotechnology and Medicine Policy

2021-10-29
MiCareo Taiwan specialises in microfluidic chip design and system integration, develops lab devices and liquid biopsy technologies for isolating rare cells, such as circulating tumor cells (CTCs), immune and stem cells. Their all-in-one, MiSelect R System has been adopted by medical centres in Taiwan to help cancer diagnosis.
Welcome partnerships with distributors in Taiwan and overseas, and collaborations in Precision Medicine and Regenerative Medicine.